Processing

Please wait...

Settings

Settings

Goto Application

1. WO2022098756 - CHIMERIC ANTIGEN RECEPTOR CELL THERAPY

Publication Number WO/2022/098756
Publication Date 12.05.2022
International Application No. PCT/US2021/057894
International Filing Date 03.11.2021
IPC
A61K 35/17 2015.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
14Blood; Artificial blood
17Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
C07K 14/705 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435from animals; from humans
705Receptors; Cell surface antigens; Cell surface determinants
C12N 5/00 2006.1
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
5Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Applicants
  • WUGEN, INC. [US]/[US]
Inventors
  • KABAKIBI, Ayman
Agents
  • HATHAWAY, Cynthia
Priority Data
63/109,07603.11.2020US
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) CHIMERIC ANTIGEN RECEPTOR CELL THERAPY
(FR) THÉRAPIE PAR CELLULE À RÉCEPTEUR ANTIGÉNIQUE CHIMÉRIQUE
Abstract
(EN) Disclosed herein are pharmaceutical compositions and methods comprising chimeric antigen receptor (CAR)-bearing immune effector cells such as CAR-T cells for the treatment of cancers.
(FR) Sont divulguées ici des compositions pharmaceutiques et des méthodes comprenant des cellules effectrices immunitaires portant un récepteur antigénique chimérique (CAR) telles que des cellules CAR-T pour le traitement de cancers.
Latest bibliographic data on file with the International Bureau